No combination trials found
No published clinical study of the BPC-157 and TB-500 combination was identified on PubMed. Available material is preclinical work on each component or user reports.
SourceBack to search
HealingBlends
BPC-157 + TB-500
A combination of two tissue repair peptides. BPC-157 contributes localised healing and angiogenesis while TB-500 contributes systemic anti-inflammatory action and tissue remodelling. No published clinical study has tested the pairing itself in people.
- Lowest cost / mg
- $2.15/mg
- at Renova Peptides
- Vendors listed
- 52
- In stock
- 82 of 85
- listings
- COA reports
- 68
Vendor listings
Compare BPC-157 + TB-500 prices.
Show prices as
79 listings · BPC-157 + TB-500
In stock10mgseen 6d ago
In stock10mgseen 7d ago
In stock10mgseen 4d ago
In stock10mgseen 5d ago
In stock10mgseen 4d ago
In stock10mgseen 6d ago
In stock20mgseen 6d ago
In stock10mgseen 3d ago
In stock10mgseen 3d ago
In stock10mgseen 3d ago
In stock20mgseen 4d ago
In stock20mgseen 7d ago
In stock10mgseen 6d ago
In stock10mgseen 6d ago
In stock10mgseen 6d ago
In stock10mgseen 5d ago
In stock10mgseen 7d ago
In stock10mgseen 4d ago
In stock10mgseen 4d ago
In stock20mgseen 4d ago
Overview
What is BPC-157 + TB-500?
A combination of two tissue repair peptides. BPC-157 contributes localised healing and angiogenesis while TB-500 contributes systemic anti-inflammatory action and tissue remodelling. No published clinical study has tested the pairing itself in people.
- Tissue Repair
- Recovery Support
- Injury Research
What the research reports
Benefits of BPC-157 + TB-500
Outcomes described across the published BPC-157 + TB-500 literature and ongoing study. Read each as research context, not a promised result.
- 01
Combined repair mechanisms
Pairs localised angiogenic action with systemic actin regulation, which is the stated rationale for stacking the two peptides in research. Reported in research settings.
- 02
Recovery support research
Popular in athletic recovery contexts for tendon, muscle and joint work, though the combination itself has no published clinical trial. Reported in research settings.
- 03
Localised and systemic reach
BPC-157 is often injected near the injury while TB-500 is dosed systemically, giving the blend two different routes of action. Reported in research settings.
- 04
Convenience of one protocol
Combining both into a single weekly schedule reduces the number of separate protocols to track during a research period. Reported in research settings.
- 05
Component level study evidence
Each peptide has its own preclinical record, so the blend inherits the evidence of its parts rather than adding evidence of its own. Reported in research settings.
Dosage and protocol
Dosage and protocol reference
Combination protocols pair BPC-157 at 250 to 500 mcg per day with TB-500 at 2 to 5 mg twice weekly, both given subcutaneously, typically across 4 to 8 weeks of research protocol time.
- Route
- Subcutaneous injection
- Example range
- 250 mcg + 2.5 mg
- Frequency
- BPC-157 daily, TB-500 twice weekly
- Timing
- BPC-157 daily near the site. TB-500 twice weekly at a separate site.
Clinical evidence
Clinical evidence and study base
The published record, labeled by strength so you can see what is settled and what is still emerging.
BPC-157 knee pain case series
The nearest human data is a 2021 case series where 87.5 percent of knee pain patients improved on BPC 157 given alone or together with thymosin beta-4. Reported in the cited paper.
SourceThymosin beta-4 dermal review
A 2016 review of thymosin beta-4 reported faster dermal repair in chronic wounds, which is the component evidence behind the TB-500 half of this blend. Reported in the cited paper.
SourceInteractions
How it pairs with other peptides
- GHK-Cu peptide
- Added in GLOW style blends for collagen and elastin signalling alongside the two repair peptides.
- KPV peptide
- Added in KLOW style blends to target inflammatory signalling through the melanocortin derived pathway.
- Ipamorelin
- No known negative interaction. The growth hormone axis is separate from both repair mechanisms here.
- Semaglutide
- No known negative interaction. Metabolic and tissue repair pathways do not overlap meaningfully.
Questions
Frequently asked questions.
What is BPC-157 + TB-500?
BPC-157 + TB-500 is a peptide compound used in research settings. It is commonly studied for its role in healing, blends, and many researchers compare supplier quality, purity, and testing data before purchasing.
What are the research benefits of BPC-157 + TB-500?
BPC-157 + TB-500 is often evaluated for its potential influence on signaling pathways, recovery support, and targeted research applications. Research interest varies by peptide, formulation, and study design, so buyers typically review purity, dose, and independent lab verification before choosing a source.
How does BPC-157 + TB-500 work?
Like other research peptides, BPC-157 + TB-500 is typically studied for how it interacts with specific biological pathways and receptor systems. In practice, the way it is formulated, dosed, and tested matters as much as the compound itself, which is why verified suppliers and transparent COAs are important.
Is BPC-157 + TB-500 for research use only?
Yes, products like BPC-157 + TB-500 are generally intended for research, laboratory, or educational use and are not marketed as approved human therapeutics. Always follow local laws, lab safety practices, and institutional requirements before handling or studying any peptide.
What should I look for before buying BPC-157 + TB-500?
Key checks include verified COA data, peptide form and concentration, supplier reputation, stock status, and cost per mg. Comparing pricing and testing records side-by-side helps reduce the risk of buying an under-tested or misrepresented product.
